Levator-Muller’s recession using labial mucosa as a spacer in severe eyelid retraction

Neelam Pushker, Rachna Meel, Mandeep S. Bajaj

Read More

https://www.canadianjournalofophthalmology.ca/article/S0008-4182(19)30187-5/fulltext

Simultaneous ipsilateral transconjunctival repair of upper and lower eyelid retraction in thyroid-associated ophthalmopathy

Nahyoung Grace Lee, Larissa Habib, Jonathan Hall & Suzanne K. Freitag

Read More

https://www.tandfonline.com/doi/full/10.1080/01676830.2018.1474237

Technique and Results of Permanent Medial Tarsorrhaphy for Complex Eyelid Malposition

Segal, Kira L.; Elner, Susan G.; Elner, Victor M.

Read More

https://journals.lww.com/op-rs/Abstract/2019/03000/Technique_and_Results_of_Permanent_Medial.15.aspx

Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves’ orbitopathy with unilateral upper eyelid retraction

Jun Soo Byun, Jeong Kyu Lee

Read More

https://link.springer.com/article/10.1007/s00417-018-4056-z

 

Entropion and ectropion repair: a snapshot of surgical practice in the United Kingdom

Katherine Anne Mcveigh, Rhys Harrison & Rebecca Ford

Read More

https://www.tandfonline.com/doi/full/10.1080/01676830.2017.1383461

 

Lenalidomide-Associated Thyroid-Related Eyelid Retraction

Slean, Geraldine R.; Silkiss, Rona Z.

Read More

Several antineoplastic treatments have been responsible for thyroid dysfunction and thyroid eye disease. Min, Vaidya, and Becker (2011) reported a case of euthyroid Graves orbitopathy after treatment with ipilimumab with the patient displaying proptosis and myositis in the setting of normal thyroid function tests and elevated thyroid antibodies. The authors report a case of a 76-year-old woman who developed right upper lid retraction and proptosis after 2.5 years of treatment with lenalidomide for multiple myeloma. Thyroid function tests were normal: thyroid-stimulating hormone 0.808 mIU/mL, total T3 102 ng/dL, free T4 1.48 ng/dL. Thyroid antibodies were elevated: thyrotropin receptor antibody 2.26 IU/L, thyroglobulin antibody 1043.1 IU/mL, and thyroid peroxidase antibody 38 IU/mL. A nuclear medicine thyroid scan was normal. Given the possible thyroid effects from lenalidomide, patients who receive this medication should be periodically evaluated for thyroid dysfunction and thyroid eye disease.

https://journals.lww.com/op-rs/Abstract/2018/03000/Lenalidomide_Associated_Thyroid_Related_Eyelid.38.aspx

 

Re: “Postoperative Changes in Strabismus, Ductions, Exophthalmometry, and Eyelid Retraction After Orbital Decompression for Thyroid Orbitopathy”

Jordan, David R. M.D., F.R.C.S.C, F.A.C.S.; Mainville, Norman M.D., F.R.C.S.C.; Klapper, Stephen R. M.D., F.A.C.S.

 

https://journals.lww.com/op-rs/Citation/2018/03000/Re____Postoperative_Changes_in_Strabismus,.28.aspx

 

 

Rootman, Daniel B. M.D. M.S.; Golan, Shani M.D.; Pavlovich, Peter M.D.; Rootman, Jack M.D., F.R.C.S.C.

 

https://journals.lww.com/op-rs/Citation/2018/03000/Reply_re____Postoperative_Changes_in_Strabismus,.29.aspx

 

 

Upper Eyelid Response to Topical 0.5% Apraclonidine

Kirkpatrick, Christopher A.; Shriver, Erin M.; Clark, Thomas J. E.; Kardon, Randy H.

Read More

Gustatory lid retraction: an unusual congenital cranial dysinnervation disorder

Arif O. Khan, Zabila Khan

Read More

1 2